Scrip
Herceptin gets first recommendation for subset of stomach cancer patients in EU
21 December 2009
Malini Guha
Roche's (Genentech) breast cancer drug Herceptin (trastuzumab) has received its first recommendation for approval anywhere in the world, from the EU's
CHMP, for the first-line treatment of about 16% of patients with HER2-positive metastatic stomach (gastric) cancer.
Roche said that the EU was...
Please Login to read the full article.
21 December 2009
Malini Guha
Roche said that the EU was...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Herceptin filed in US for HER2-positive stomach cancer
- Erbitux disappoints in first Phase III trial in early-stage colon cancer
- Nexavar fails second Phase III trial in newly diagnosed advanced lung cancer
- Vectibix clears PFS but survival hurdle still awaits in colorectal cancer
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
